Tim Tupa

AngioDynamics Device Manager | AlphaVac | AngioVac | Connecticut, Westchester & the Bronx

[AngioDynamics, Inc. @angiodynamics]

The first patient has been successfully treated in the RECOVER-AV Study! Congratulations to @alearasz & the team in Poznan, Poland!

https://t.co/8siXhLGE2E

https://t.co/XRzPxP6tIZ
The AlphaVac System is not available in all countries. Consult your AngioDynamics representative.

[olek.araszkiewicz @alearasz]

Thrilled to share we performed an aspiration thrombectomy in a 34yo male with IHR PE in normotensive shock 🫀🫁🔥Great result with AlphaVac F18 @angiodynamics 🎯 On table improvement. FIRST patient worldwide enrolled in the RECOVER-AV study! 🚀